Connection
Cecilia Low Wang to Blood Glucose
This is a "connection" page, showing publications Cecilia Low Wang has written about Blood Glucose.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.733 |
|
|
|
-
Low Wang CC, Everett BM, Burman KD, Wilson PWF. Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs? Circulation. 2019 04 02; 139(14):1741-1743.
Score: 0.357
-
Low Wang CC, Draznin B. USE OF NPH INSULIN FOR GLUCOCORTICOID-INDUCED HYPERGLYCEMIA. Endocr Pract. 2016 Feb; 22(2):271-3.
Score: 0.286
-
Abushamat LA, Schauer IE, Low Wang CC, Mitchell S, Herlache L, Bridenstine M, Durbin R, Snell-Bergeon JK, Regensteiner JG, Reusch JE. Rosiglitazone improves insulin resistance but does not improve exercise capacity in individuals with impaired glucose tolerance: A randomized clinical study. J Investig Med. 2024 Mar; 72(3):294-304.
Score: 0.031
-
Sirlanci M, Levine ME, Low Wang CC, Albers DJ, Stuart AM. A simple modeling framework for prediction in the human glucose-insulin system. Chaos. 2023 Jul 01; 33(7).
Score: 0.030
-
Mubeen F, Low Wang CC, Al Maradni A, Shivaswamy V, Sadhu AR. Digital Health and Shared Decision-Making in Diabetes Care - A Survey Initiative in Patients and Clinicians. Endocr Pract. 2023 Jul; 29(7):538-545.
Score: 0.030